Clinical Trial Update: Lipid Research Clinics Coronary Primary Prevention Trial (CPPT) [Phase 3]

View source ↗

Summary

A Phase 3 trial update reporting completion of the Lipid Research Clinics Coronary Primary Prevention Trial (CPPT), evaluating a cholesterol-lowering therapy fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Coronary Heart Disease
• Myocardial Ischemia

Drugs mentioned

• Cholestyramine (cholestyramine)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Coronary Disease | Phase 3 | Status: COMPLETED